| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 43.538 | 114.415 | 138.326 | 149.442 | 168.333 | 213.285 | 251.108 | 281.677 |
| Total Income - EUR | - | 0 | 44.049 | 114.416 | 139.479 | 150.793 | 168.335 | 213.286 | 251.146 | 287.843 |
| Total Expenses - EUR | - | 1.214 | 42.562 | 92.782 | 131.981 | 136.897 | 150.328 | 203.541 | 213.837 | 245.400 |
| Gross Profit/Loss - EUR | - | -1.214 | 1.487 | 21.633 | 7.498 | 13.896 | 18.007 | 9.745 | 37.309 | 42.443 |
| Net Profit/Loss - EUR | - | -1.214 | 1.046 | 20.489 | 6.112 | 12.475 | 16.525 | 7.931 | 35.096 | 34.218 |
| Employees | - | 1 | 2 | 2 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Flavisor Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 94 | 0 | 0 | 8.678 | 8.029 | 7.747 | 6.832 | 12.497 | 31.947 |
| Current Assets | - | 355 | 15.671 | 36.689 | 44.103 | 69.403 | 97.479 | 112.950 | 119.522 | 136.213 |
| Inventories | - | 0 | 8.338 | 24.320 | 22.104 | 46.095 | 58.966 | 69.750 | 78.600 | 85.120 |
| Receivables | - | 0 | 5.169 | 11.086 | 16.139 | 16.605 | 17.595 | 19.290 | 17.416 | 25.524 |
| Cash | - | 355 | 2.164 | 1.282 | 5.860 | 6.704 | 20.919 | 23.910 | 23.506 | 25.569 |
| Shareholders Funds | - | -1.170 | -104 | 20.387 | 22.065 | 37.169 | 52.870 | 60.966 | 95.877 | 129.559 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.619 | 15.774 | 16.301 | 30.716 | 40.263 | 52.355 | 58.816 | 36.142 | 38.601 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Flavisor Med S.r.l.